朗逸品牌怎么样 申请店铺

我要投票 朗逸在滴眼液行业中的票数:405 更新时间:2025-07-15
朗逸是哪个国家的品牌?「朗逸」是 四川升和药业股份有限公司 旗下著名品牌。该品牌发源于四川省成都市,由创始人廖远征在1993-09-21期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力朗逸品牌出海!将品牌入驻外推网,定制朗逸品牌推广信息,可以显著提高朗逸产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

朗逸怎么样

四川升和药业股份有限公司,朗逸鱼腥草滴眼液,十大滴眼液品牌,集药品研究/开发生产和医药贸易为一体的高新技术医药企业


四川升和药业股份有限公司是集药品研究、开发、生产、医药投资为一体的企业。

公司下属三个制药分公司、一个省级企业技术中心。拥有小容量注射剂、大容量注射剂、片剂、硬胶囊剂、颗粒剂、滴眼剂、合剂、糖浆剂、口服溶液剂、原料药等20多条生产线;生产10个剂型、240个品种规格的药品及4个品种规格的保健食品。

产品体系拥有51项专利(含发明专利32项)、品种15个、中药保护品种6个;151个产品剂型中,95个入选国家医保目录,39个入选国家基本药物目录。主导产品为中药注射剂系列、眼科药物系列、专科固体制剂系列、抗肿瘤药物系列等,是国内中药注射剂领域核心企业之一。专业化销售和推广网络覆盖全国33个省(市)、500多家大中型医药经营企业和近万家各类终端医院;主导产品参麦注射液、香丹注射液、丹参注射液、鱼腥草滴眼液、肤痒颗粒、糖脉康颗粒等均位列国内市场占有率前5名。

公司的发展战略方向是现代中药制造以及围绕制药而延伸的医药流通、医疗服务产业链。未来5~10年,主要发展中药注射剂、抗肿瘤药物、及眼科和内分泌专科药物等产品,跻身中国主要中成药制药企业行列,成为专业化程度较高的集药品研发、药品生产、医药流通、医疗服务为一体的大型高科技医药产业集团公司。


Sichuan Shenghe Pharmaceutical Co., Ltd., Langyi Houttuynia eyedrop, one of the top ten eyedrop brands, is a high-tech pharmaceutical enterprise integrating pharmaceutical research, development, production and trade. Sichuan Shenghe Pharmaceutical Co., Ltd. is an enterprise integrating pharmaceutical research, development, production and investment. The company has three pharmaceutical branches and one provincial enterprise technology center. It has more than 20 production lines, including small volume injection, large volume injection, tablet, hard capsule, granule, eye drops, mixture, syrup, oral solution, API, etc.; it produces 10 dosage forms, 240 varieties and specifications of drugs and 4 varieties and specifications of health food. In the product system, there are 51 patents (including 32 invention patents), 15 varieties and 6 varieties protected by traditional Chinese medicine; of the 151 product formulations, 95 are listed in the national medical insurance catalog and 39 are listed in the national essential drug catalog. The leading products are traditional Chinese medicine injection series, ophthalmic medicine series, specialized solid preparation series, anti-tumor medicine series, etc. it is one of the core enterprises in the field of traditional Chinese medicine injection in China. The specialized sales and promotion network covers 33 provinces (cities), more than 500 large and medium-sized pharmaceutical business enterprises and nearly 10000 various terminal hospitals in China; the leading products Shenmai injection, Xiangdan injection, Danshen injection, Houttuynia eyedrops, Fuyang granules, Tangmaikang granules, etc. all rank in the top 5 in the domestic market share. The development strategic direction of the company is the modern Chinese medicine manufacturing and the pharmaceutical circulation and medical service industry chain extended around the pharmaceutical industry. In the next 5-10 years, we will mainly develop products such as traditional Chinese medicine injection, anti-tumor drugs, ophthalmic and endocrine specialty drugs, etc., and become one of the major Chinese patent medicine pharmaceutical enterprises in China. We will become a large high-tech pharmaceutical industry group company with high degree of specialization, integrating drug research and development, drug production, drug circulation and medical services.

本文链接: https://brand.waitui.com/402c34d5b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

德国央行:2025年该国经济或持续面临零增长困境

当地时间14日,德国央行在其月度报告中披露,德国经济在全球市场的竞争力正在流失。报告指出,“自2017年起,德国出口所占的市场份额便持续下滑。”出口市场的疲软态势,明显加剧了德国经济当前所面临的危机。照此趋势发展,到2025年,德国经济极有可能连续第三年陷入零增长的困境。(央视新闻)

2小时前

美股大型科技股盘前涨跌不一,特斯拉涨超1%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,特斯拉涨超1%,奈飞涨0.52%,英伟达涨0.31%,亚马逊涨0.06%;苹果跌0.79%,微软跌0.4%,Meta跌0.17%,谷歌跌0.12%。

2小时前

媒体:巴西议员计划赴美讨论关税问题

巴西议员将于9月赴美与美国官员讨论唐纳德·特朗普宣布的关税措施,CNN Brasil援引参议院外交关系委员会主席的话报道。据报道,尽管公布这一计划行程日期,但部分议员正努力将访问时间提前至7月。四名议员将参加此次访问。(新浪财经)

2小时前

考拉悠然推出悠然无界大模型

36氪获悉,考拉悠然推出悠然无界大模型(Uran Boundless),该模型采用轻量化参数架构,构建出首个面向工业级场景的空间智能闭环系统。其7B与32B版本在多模态理解、物理常识推理、具身执行等任务中刷新多项SOTA记录,部分能力超越GPT-4o、Gemini 2.5等国际模型及Qwen等开源模型。

2小时前

热门中概股美股盘前多数上涨,蔚来涨超5%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,蔚来涨超5%,理想汽车涨超2%,阿里巴巴、哔哩哔哩涨超1%,小鹏汽车涨0.75%,京东涨0.29%,拼多多涨0.23%,百度跌超1%。

2小时前

本页详细列出关于朗逸的品牌信息,含品牌所属公司介绍,朗逸所处行业的品牌地位及优势。
咨询